Scholars Central

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The aim of our study was to evaluate the effect on cancer cell viability and proliferation of some well-known commercially available drugs used in clinical practice for the treatment of other diseases: disulfiram (applied in the treatment of alcoholism), statins (lipid-lowering medication) and non-steroidal anti-inflammatory agents (meloxicam as well as its Zn(II), Co(II), Co(II) and Ni(II) complexes). The cytotoxic activity of the compounds was investigated in retrovirus-transformed LSCC-SF-Mc29 chicken hepatoma and LSR-SF-SR rat sarcoma cells that express oncogenes v-myc and v-src, respectively (in the case of disulfiram and statins) as well as in human cell lines established from breast MCF-7), colorectal (HT29) and liver (HepG2) cancer, non-small cell lung cancer (A549), uterine cervical carcinoma (HeLa) and glioblastoma multiforme (8MGBA). Lep-3 non-tumor human embryonic fibroblastoid cells were also used for comparative purposes. The experiments were performed by MTT test, neutral red uptake assay, crystal violet staining, hematoxylin and eosin staining, double staining with acridine orange and propidium iodide, Comet assay, 3D-colony forming method. The results obtained reveal that applied at concentrations of 1-50 ?g/ml (disulfiram and statins) and 10-500 ?g/ml (meloxicam and its metal complexes) the examined compounds decrease in a time- and concentration-dependent manner viability / 2D- and 3D-growth of the treated cells. Metal complexes of meloxicam are more effective cytotoxic agents as compared to meloxicam alone. Non-tumor Lep-3 cells are also sensitive to the cytotoxic activity of the compounds tested. Acknowledgement: Supported by National Science Fund, Bulgarian Ministry of Education and Science (Grant ??? ?????? ?? 02 30/ 12.12.2014) and a bilateral project between Bulgarian Academy of Sciences and Romanian Academy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Pharmaceutica Analytica Acta.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutica Analytica Acta
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Radostina Ivaylova Alexandrova”
  • BylineArticles whose byline prints “Desislav Dinev”
  • BylineArticles whose byline prints “Tanya Zhivkova”
  • BylineArticles whose byline prints “Milena Georgieva”
  • BylineArticles whose byline prints “Georgi Miloshev”
  • BylineArticles whose byline prints “RossenSpasov”
  • BylineArticles whose byline prints “Albena Alexandrova”
  • BylineArticles whose byline prints “GabrielaMarinescu”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels